Global Active Pharmaceutical Ingredient Market Report – Research, Industry Analysis Reports and Market Demands

Global Active Pharmaceutical Ingredient Market Research Report 2012-2024

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Objectives of Research
- 1.1.1 Definition
- 1.1.2 Specifications
1.2 Market Segment
- 1.2.1 by Type
  - 1.2.1.1 Synthetic API
  - 1.2.1.2 Biotech API
  - 1.2.1.3 Others
- 1.2.2 by Application
  - 1.2.2.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  - 1.2.2.2 Oncology Drugs
  - 1.2.2.3 Anti-diabetic Drugs
  - 1.2.2.4 Cardiovascular Drugs
  - 1.2.2.5 Central Nervous System Drugs (CNS Drugs)
  - 1.2.2.6 Musculoskeletal Drugs
  - 1.2.2.7 Other Drugs
- 1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
- 2.3.1 SWOT
- 2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size
- 4.1.1 Synthetic API Market, 2013-2018
- 4.1.2 Biotech API Market, 2013-2018
- 4.1.3 Others Market, 2013-2018
4.2 Market Forecast
- 4.2.1 Synthetic API Market Forecast, 2019-2024
- 4.2.2 Biotech API Market Forecast, 2019-2024
- 4.2.3 Others Market Forecast, 2019-2024

5 Market Segmentation by Application

5.1 Market Size
- 5.1.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, 2013-2018
- 5.1.2 Oncology Drugs Market, 2013-2018
- 5.1.3 Anti-diabetic Drugs Market, 2013-2018
- 5.1.4 Cardiovascular Drugs Market, 2013-2018
- 5.1.5 Central Nervous System Drugs (CNS Drugs) Market, 2013-2018
- 5.1.6 Musculoskeletal Drugs Market, 2013-2018
- 5.1.7 Other Drugs Market, 2013-2018
5.2 Market Forecast
- 5.2.1 Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market Forecast, 2019-2024
- 5.2.2 Oncology Drugs Market Forecast, 2019-2024
- 5.2.3 Anti-diabetic Drugs Market Forecast, 2019-2024
- 5.2.4 Cardiovascular Drugs Market Forecast, 2019-2024
- 5.2.5 Central Nervous System Drugs (CNS Drugs) Market Forecast, 2019-2024
- 5.2.6 Musculoskeletal Drugs Market Forecast, 2019-2024
- 5.2.7 Other Drugs Market Forecast, 2019-2024

6 Market Segmentation by Region

6.1 Market Size
- 6.1.1 Asia-Pacific
  - 6.1.1.1 Asia-Pacific Market, 2012-2018
  - 6.1.1.2 Asia-Pacific Market by Type
  - 6.1.1.3 Asia-Pacific Market by Application
- 6.1.2 North America
  - 6.1.2.1 North America Market, 2012-2018
  - 6.1.2.2 North America Market by Type
  - 6.1.2.3 North America Market by Application
- 6.1.3 Europe
  - 6.1.3.1 Europe Market, 2012-2018
  - 6.1.3.2 Europe Market by Type
  - 6.1.3.3 Europe Market by Application
- 6.1.4 South America
  - 6.1.4.1 South America Market, 2012-2018
  - 6.1.4.2 South America Market by Type
  - 6.1.4.3 South America Market by Application
- 6.1.5 Middle East & Africa
  - 6.1.5.1 Middle East & Africa Market, 2012-2018
  - 6.1.5.2 Middle East & Africa Market by Type
  - 6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
- 6.2.1 Asia-Pacific Market Forecast, 2019-2024
- 6.2.2 North America Market Forecast, 2019-2024
- 6.2.3 Europe Market Forecast, 2019-2024
- 6.2.4 South America Market Forecast, 2019-2024
- 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 Major Vendors

9 Conclusion

Description

Summary
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active component of a drug, excipients are the inactive or inert substances present in a drug.
The global Active Pharmaceutical Ingredient market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Synthetic API
Biotech API
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
Bachem
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Oncology Drugs
Anti-diabetic Drugs
Cardiovascular Drugs
Central Nervous System Drugs (CNS Drugs)
Musculoskeletal Drugs
Other Drugs
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa